Who is CYDY_ invest??? I looked back at this post and

New Post Public Reply Private Reply Replies (0) Message Board
Goosebumps CYDY_Invest #92051
627

Who is CYDY_ invest??? I looked back at this post and found that there is much history but only one post ever before. Makes you wonder who didn’t want to be recognized and already uses this board.

Either way... it is good advice and should be read occasionally. It will inform you into what the history has been and help understand that the old management wasn’t what all that great and now they want back in... just give it another read with an OPEN MIND...so you know who we are dealing with.


Hi,

I’ve been an investor for many years and have heard every conf call. Regarding this 5% group, I don’t trust them, and I don’t think anyone should. So it really doesn’t matter what they say, if they’re not credible. As mentioned, former employees Caracciolo and Pestell are part of this group.
Thank you Ohm, for reminding the message board that it was Caracciolo who brought the worthless Prostate test, which has been shelved, and gave Pestell 8 million shares. Pestell was appointed as the CMO (I don’t think he actually has his Board license in the USA, which made no sense to be the CMO.)

“We are very pleased to expand and strengthen our relationship with Dr. Pestell...,” said Anthony Caracciolo, CytoDyn’s Chairman. “As we separately announced today, we have signed a non-binding letter of intent for the proposed acquisition of ProstaGene.” (7/12/18)

This was an absurd decision from Caracciolo to acquire the Prostate test. In addition, I remember during the couple conference calls Caracciolo actually was a part of, I was totally unimpressed by Caraccoilo’s speaking ability and grasp of situations investors brought up. He kept us in the dark for way over a year, and essentially no progress happened with the company. Furthermore, Pestell was terminated by the Board.

So why should we believe this group?

Besides these two individuals, this 5% group includes 2 pizza shop owners, a realtor, a bunch of “consultants.” What possible earth-shattering wisdom will they offer that could make any difference to the value of the company? There is nothing to gain and everything to lose. Regardless of what they advise, they’re not trustworthy. Their true motives cannot be trusted.

I’m very concerned they will take over and put their people in place to sell out cheap to Big Pharma, or some other horrible situation will occur.

At this point, the only thing that really counts are well designed trials and positive data. There’s been tremendous progress this year. There are multiple Covid trials, NASH trial, Cancer basket, BLA submission. There’s more money in the bank than ever in Cytodyn’s history. Let’s be stay the course! We will have data readouts in the very near future and that will mean everything!

Certainly, I’ve been frustrated by Nader’s communication, however he has improved. Also, Dr. Jay vouches for his trustworthiness (on his recent podcast) which is important.

I am very impressed and encouraged by Dr. Scott Kelly. I believe he is a good man, a patient advocate, and he goes the extra mile for Covid patients trying to get Lernonlimab. He’s smart, articulate, knows the science. Listen to the TNBC cancer presentation. He formed the scientific advisory board with top notch physician scientists and leaders in medicine.

As a shareholder, I want minimum dilution, to explore and ultimately get approval for a wide variety of indications, grow the company organically and not selling out cheap to Big Pharma! These align with the goals of Nader, Kelly, and the Board. There’s been tremendous progress this last year and I want to keep the momentum. The FDA letter and this 5% group are bumps in the road, but just gotta keep moving forward, and fully reject this 5% group

Read More: https://investorshangout.com/post/view?id=614...z6wg8H3Chz

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Coca-Cola's Recent Unusual Options Trends

Updated Category News Views 259

Analyzing Coca-Cola's Recent Options Activity Investors are showing a bearish trend toward Coca-Cola (KO), which is an important indicator for retail traders monitoring investment trends. The recent unusual options activity suggests that these investors may possess insights not yet shared with the public. Thus, individual traders should be particularly attentive to these...

Continue Reading
Sustainable Palm Oil Market Growth Driven by AI Insights

Updated Category News Views 136

Exploring the Growth of the Sustainable Palm Oil Market The sustainable palm oil market is currently on the rise, fueled by a growing demand for trans-fat-free products and innovations in eco-friendly farming practices. This growth is expected to hit around USD 2.75 billion by 2028, reflecting a solid compound annual growth rate (CAGR) of about 5.24% in the coming years....

Continue Reading
Grilling Safety Tips from Ferrellgas This Labor Day

Updated Category News Views 82

Grilling Safety Tips from Ferrellgas This Labor Day As we gear up for one of the biggest grilling holidays of the year, it's essential to keep safety in mind while savoring delicious meals with family and friends. Ferrellgas Partners, L.P. is taking this opportunity to remind customers about the significance of safe grilling practices this Labor Day. This holiday not only...

Continue Reading
Solstice Gold Secures Funding Through Successful Placement Deal

Updated Category News Views 127

Solstice Gold Completes Successful Private Placement Financing Solstice Gold Corp. (“Solstice”, “we”, “our”, or the “Company”) is thrilled to announce the successful closing of its private placement financing. This significant financial milestone comes with gross proceeds of approximately $150,000 from the issuance of 6,600,000 shares. This private...

Continue Reading
Avanos Medical Introduces Innovative CORGRIP SR System

Updated Category News Views 32

Avanos Medical Launches New CORGRIP SR Advancement to reduce dislodgement in feeding tube retention systems Avanos Medical, Inc. (NYSE: AVNS) recently announced an exciting development in its Enteral Feeding portfolio with the launch of the CORGRIP SR Nasogastric/Nasointestinal Tube Retention System. This innovative design aims to provide enhanced support and security for...

Continue Reading